Trump-era tariffs are benefiting certain AI stocks, exemplified by Liquidia Corp. and its product Yutrepia, which treats pulmonary hypertension and interstitial lung disease.
3 reports, 1 independent
Updated Sep 5
Gone quiet
- Reports
- 3
- Developments
- 5
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trump-era tariffs are benefiting certain AI stocks, exemplified by Liquidia Corp. and its product Yutrepia, which treats pulmonary hypertension and interstitial lung disease.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- HCRx provided $50M funding to Liquidia, accelerating YUTREPIA's commercial launch while United Therapeutics filed an injunction request.Sub-event
- The FDA approved YUTREPIA, a product from Liquidia Corporation, marking a key milestone.Sub-event
Specific case of how Trump-era tariffs are benefiting AI stocks via Liquidia Corp.1 source
YUTREPIA adoption is stronger than expected, benefiting from Trump-era tariffs.1 source
FDA approved YUTREPIA™ for pulmonary hypertension, and Bank of America raised its price target.1 source
Keep exploring
Part of
Investors are seeking greater upside potential in AI stocks. Inflation and utilization worries are impacting medtech valuations, which could benefit from tariffs.Also in this story
- Rhythm develops precision medicines for rare genetic diseases, benefiting from tariffs and attracting analyst buy ratings.
- Major investment firms like Bridgewater and Berkshire Hathaway increased their exposure to Big Tech stocks amid the AI boom.
- Quest Resource Holding Corporation, headquartered in The Colony, Texas, is mentioned in the context of AI stocks and market upside potential.
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Related events
- Trump-era tariffs are reportedly benefiting certain AI stocks, coinciding with the spin-off of Millrose Properties, Inc. from Lennar Corporation.
- Sable Offshore Corp., a Houston-based company, is developing the Santa Ynez Unit offshore California, leveraging a court ruling to restart Las Flores pipelines, concurrent with AI stocks benefiting from Trump-era tariffs.
- Trump tariffs and onshoring benefit AI stocks, leading to automation and robotics support agreements involving Amazon and Richtech Robotics.
- AI stocks are benefiting from Trump-era tariffs, with Morningstar and ClearBridge providing market analysis on growth and upside potential.
- Barclays raised its price target for Okta, noting that AI stocks are benefiting from the onshoring trend and Trump-era tariffs.
Coverage
Newest first; wire copies grouped- Insider MonkeyJefferies Highlights Yutrepia’s Market Edge in Supporting a Buy on Liquidia (LQDA) Liquidia Corp. (NASDAQ:LQDA) is one of the most shorted stocks right now. On August 15, Jefferies analyst Amy Li ini
- Insider MonkeyBTIG Raises Price Target for Liquidia (LQDA), Keeps Buy Rating Liquidia Corporation (NASDAQ:LQDA) is one of the 10 Hot Mid Cap Stocks to Buy Now. On August 13, BTIG increased its price target for Liq
- Insider MonkeyCourt Victory and Fresh Funding Propel Growth at Liquidia Corporation Liquidia Corporation (NASDAQ:LQDA) is one of the 11 Best Short Squeeze Stocks to Buy Now. Price targets raised by analysts follow